Clinical Trial Update: CT-011 MAb in DLBCL Patients Following ASCT [Phase 2]

View source ↗

Summary

Phase 2 trial results for the CT-011 monoclonal antibody in diffuse large B-cell lymphoma patients following autologous stem cell transplant have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Diffuse Large B-cell Lymphoma Mixed Cell Type
• Mediastinal Large B-cell Lymphoma

Drugs mentioned

• CT-011 monoclonal antibody (CT-011)

Snippet

Sponsor: CureTech Ltd | Conditions: Lymphoma, Large Cell, Diffuse, Lymphoma, Mixed Cell, Diffuse | Phase 2 | Status: COMPLETED | Results posted: 2014-09-12